Percent of Patients Achieving Full Dose Ramipril, Telmisartan or placebo at the end of the ONTARGET and TRANSCEND studies.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Percent_of_Patients_Achieving_Full_Dose_Ramipril_Telmisartan_or_placebo_at_the_end_of_the_ONTARGET_and_TRANSCEND_studies_/481912
下载链接
链接失效反馈官方服务：
资源简介：
*Risk in telmisartan/ramipril group.¶p-value (telmisartan vs. ramipril).**Risk in telmisartan/placebo group.δp-value (telmisartan vs. placebo).†p-value (asians vs. non-asians).§p for interaction.
创建时间：
2015-12-02
